Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Nasopharyngeal carcinoma.

A T C Chan¹, P M L Teo, P J Johnson

¹Prince of Wales Hospital, Sir Y. K. Pao Cancer Center, Chinese University of Hong Kong, People's Republic of China. anthonytcchan@cuhk.edu.hk

Annals of Oncology : Official Journal of the European Society for Medical Oncology

|August 15, 2002

Summary

Nasopharyngeal carcinoma (NPC), prevalent in southern China, involves genetic factors and Epstein-Barr virus (EBV). Circulating EBV-DNA aids in monitoring and prognostication for NPC patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mental health and employment outcomes in working-age US adults, 2010-2019.

Occupational medicine (Oxford, England)·2024

Same author

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Same author

Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Same author

Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study.

The British journal of surgery·2021

Same author

Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma.

AJNR. American journal of neuroradiology·2020

Area of Science:

Oncology
Virology
Genetics

Background:

Nasopharyngeal carcinoma (NPC) is a significant health concern in southern China.
Genetic abnormalities and Epstein-Barr virus (EBV) infection are key factors in NPC development.
Circulating EBV-DNA is a recognized biomarker for NPC prognostication and patient monitoring.

Purpose of the Study:

To summarize the current understanding of nasopharyngeal carcinoma pathogenesis and treatment.
To highlight the role of Epstein-Barr virus (EBV) in NPC.
To discuss the current and future therapeutic strategies for NPC.

Main Methods:

Review of existing literature on NPC.
Analysis of the role of genetic factors and EBV in NPC pathogenesis.

Related Experiment Videos

Evaluation of current treatment modalities including radiotherapy and chemotherapy.

Discussion of emerging therapeutic approaches.

Main Results:

NPC pathogenesis is linked to genetic predispositions and EBV infection.
Circulating EBV-DNA levels correlate with prognosis and disease monitoring.
Concurrent cisplatin and radiotherapy improve survival for advanced NPC.
Targeting agents and immunotherapy represent promising future treatments.

Conclusions:

NPC management relies on understanding its etiological factors, particularly EBV.
Current treatments like chemoradiotherapy are effective for advanced stages.
Future research into targeted therapies and immunotherapies holds potential for improved NPC outcomes.